Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

86.04
Delayed Data
As of 4:02pm ET
 -0.30 / -0.35%
Today’s Change
66.93
Today|||52-Week Range
86.90
+18.12%
Year-to-Date
What to Expect from Big Pharmas After J&J's Solid Q3 Results?
4:54pm / Zacks.com - Paid Partner Content
Let's Talk About CAR-T
Oct 16 / GuruFocus News - Paid Partner Content
What's in the Cards for Novartis (NVS) This Earnings Season?
7:41am / Zacks.com - Paid Partner Content
Bristol-Myers (BMY), TARGET Extend Partnership for NASH Study
Oct 13 / Zacks.com - Paid Partner Content
Aerie (AERI) Up on FDA Review Committee Result for Rhopressa
Oct 17 / Zacks.com - Paid Partner Content
Lilly's Verzenio Gets Priority Review in First-Line Setting
Oct 13 / Zacks.com - Paid Partner Content
Innovative Pipelines & Regulatory Catalysts to Drive Pharma Stocks
Oct 17 / Zacks.com - Paid Partner Content
FDA Advisory Committee Greenlights First Gene Therapy for Inherited Disorder
Oct 12 / TheStreet.com - Paid Partner Content
Let's Talk About CAR-T
Oct 16 / GuruFocus News - Paid Partner Content
Non-Alcoholic Steatohepatitis 2017 Progress Update
Oct 12 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close86.34
Today’s open86.17
Day’s range85.88 - 86.31
Volume1,120,561
Average volume (3 months)1,656,948
Market cap$202.3B
Dividend yield3.16%
Data as of 4:02pm ET, 10/18/2017

Growth & Valuation

Earnings growth (last year)-61.91%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.63%
Revenue growth (last year)-1.90%
P/E ratio31.4
Price/Sales3.61
Price/Book2.72

Competitors

 Today’s
change
Today’s
% change
PFEPfizer-0.37-1.02%
MRKMerck+0.29+0.46%
SNYSanofi-0.06-0.12%
ABBVAbbVie+3.87+4.20%
Data as of 4:02pm ET, 10/18/2017

Financials

Next reporting dateOctober 24, 2017
EPS forecast (this quarter)$1.23
Annual revenue (last year)$48.4B
Annual profit (last year)$6.7B
Net profit margin13.83%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Joseph Jimenez
Chief Financial Officer
Harry Kirsch
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts